Free Trial
NASDAQ:LFST

LifeStance Health Group (LFST) Stock Price, News & Analysis

LifeStance Health Group logo
$4.37 +0.51 (+13.21%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$4.36 0.00 (-0.11%)
As of 08/8/2025 07:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About LifeStance Health Group Stock (NASDAQ:LFST)

Key Stats

Today's Range
$3.90
$4.39
50-Day Range
$3.79
$5.96
52-Week Range
$3.74
$8.61
Volume
7.39 million shs
Average Volume
2.47 million shs
Market Capitalization
$1.70 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.50
Consensus Rating
Moderate Buy

Company Overview

LifeStance Health Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
64th Percentile Overall Score

LFST MarketRank™: 

LifeStance Health Group scored higher than 64% of companies evaluated by MarketBeat, and ranked 347th out of 923 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    LifeStance Health Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.86, and is based on 5 buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    LifeStance Health Group has only been the subject of 2 research reports in the past 90 days.

  • Read more about LifeStance Health Group's stock forecast and price target.
  • Earnings Growth

    Earnings for LifeStance Health Group are expected to grow in the coming year, from ($0.18) to ($0.14) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of LifeStance Health Group is -87.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of LifeStance Health Group is -87.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    LifeStance Health Group has a P/B Ratio of 1.16. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    6.22% of the float of LifeStance Health Group has been sold short.
  • Short Interest Ratio / Days to Cover

    LifeStance Health Group has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in LifeStance Health Group has recently decreased by 7.73%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    LifeStance Health Group does not currently pay a dividend.

  • Dividend Growth

    LifeStance Health Group does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    6.22% of the float of LifeStance Health Group has been sold short.
  • Short Interest Ratio / Days to Cover

    LifeStance Health Group has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in LifeStance Health Group has recently decreased by 7.73%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    LifeStance Health Group has a news sentiment score of 0.86. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.38 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 13 news articles for LifeStance Health Group this week, compared to 3 articles on an average week.
  • Search Interest

    Only 8 people have searched for LFST on MarketBeat in the last 30 days. This is a decrease of -27% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, LifeStance Health Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $95,040.00 in company stock.

  • Percentage Held by Insiders

    Only 3.20% of the stock of LifeStance Health Group is held by insiders.

  • Percentage Held by Institutions

    85.50% of the stock of LifeStance Health Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about LifeStance Health Group's insider trading history.
Receive LFST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeStance Health Group and its competitors with MarketBeat's FREE daily newsletter.

LFST Stock News Headlines

Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.
LifeStance Reports Second Quarter 2025 Results
See More Headlines

LFST Stock Analysis - Frequently Asked Questions

LifeStance Health Group's stock was trading at $7.37 at the beginning of 2025. Since then, LFST shares have decreased by 40.7% and is now trading at $4.37.

LifeStance Health Group, Inc. (NASDAQ:LFST) issued its earnings results on Thursday, August, 7th. The company reported ($0.01) EPS for the quarter, topping the consensus estimate of ($0.03) by $0.02. LifeStance Health Group's quarterly revenue was up 10.6% compared to the same quarter last year.
Read the conference call transcript
.

LifeStance Health Group (LFST) raised $640 million in an IPO on Thursday, June 10th 2021. The company issued 40,000,000 shares at a price of $15.00-$17.00 per share. Morgan Stanley, Goldman Sachs, J.P. Morgan, Jefferies, TPG Capital BD LLC, UBS Investment Bank and William Blair acted as the underwriters for the IPO and Capital One Securities, AmeriVet, Drexel Hamilton, R. Seelaus & Co. and Siebert Williams Shank were co-managers.

LifeStance Health Group's top institutional shareholders include Jennison Associates LLC (1.87%), Geode Capital Management LLC (0.87%), First Eagle Investment Management LLC (0.31%) and TD Asset Management Inc (0.04%). Insiders that own company stock include Summit Partners Growth Equity, Warren Gouk, Kevin Michael Mullins, Robert Bessler, Ryan Pardo, Danish J Qureshi, David Bourdon, Lisa K Miller, Anisha Patel-Dunn, Ann Varanakis, Paula Cipollone and Ujjwal Ramtekkar.
View institutional ownership trends
.

Shares of LFST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that LifeStance Health Group investors own include Waste Connections (WCN), American Water Works (AWK), The RMR Group (RMR), AU Optronics (AUOTY), DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM).

Company Calendar

Last Earnings
8/07/2025
Today
8/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - OUTP/HM CRE
Sub-Industry
Healthcare
Current Symbol
NASDAQ:LFST
CIK
1845257
Fax
N/A
Employees
10,218
Year Founded
N/A

Price Target and Rating

High Price Target
$10.00
Low Price Target
$7.00
Potential Upside/Downside
+94.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.86
Research Coverage
7 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.10)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$57.44 million
Net Margins
-1.23%
Pretax Margin
-2.99%
Return on Equity
-1.12%
Return on Assets
-0.77%

Debt

Debt-to-Equity Ratio
0.19
Current Ratio
1.47
Quick Ratio
1.47

Sales & Book Value

Annual Sales
$1.25 billion
Price / Sales
1.36
Cash Flow
$0.04 per share
Price / Cash Flow
97.34
Book Value
$3.78 per share
Price / Book
1.16

Miscellaneous

Outstanding Shares
388,880,000
Free Float
376,432,000
Market Cap
$1.70 billion
Optionable
Optionable
Beta
1.13
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:LFST) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners